Skip to main content
SpringerLink
Log in

Risperidone elevates prolactin levels to a greater extent among patients with paranoid schizophrenia

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Segal M, Avital A, Derevenski A, Berstein S, Sandbank S, Weizman A.Prolactin serum levels in paranoid versus nonparanoid male schizophrenia patients treated with risperidone. International Clinical Psychopharmacology 22: 192-196, No. 4, Jul 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risperidone elevates prolactin levels to a greater extent among patients with paranoid schizophrenia. React. Wkly. 1168, 3 (2007). https://doi.org/10.2165/00128415-200711680-00007

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200711680-00007

Keywords

Search

Navigation